|
CNOT6 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.229000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.222400E-02 |
| Normal-vs-Stage2 |
8.034200E-01 |
| Normal-vs-Stage3 |
6.432000E-01 |
| Normal-vs-Stage4 |
7.024600E-01 |
| Stage1-vs-Stage2 |
4.179600E-01 |
| Stage1-vs-Stage3 |
4.915800E-01 |
| Stage1-vs-Stage4 |
5.138800E-01 |
| Stage2-vs-Stage3 |
8.809600E-01 |
| Stage2-vs-Stage4 |
6.622200E-01 |
| Stage3-vs-Stage4 |
6.258000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.106600E-01 |
| Normal-vs-AfricanAmerican |
2.649200E-01 |
| Normal-vs-Asian |
6.250400E-01 |
| Caucasian-vs-AfricanAmerican |
9.138000E-01 |
| Caucasian-vs-Asian |
8.302600E-01 |
| AfricanAmerican-vs-Asian |
8.728400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.036000E-02 |
| Normal-vs-Female |
5.987600E-01 |
| Male-vs-Female |
5.254000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.427600E-01 |
| Normal-vs-Extreme_Weight |
1.120380E-02 |
| Normal-vs-Obese |
5.755600E-01 |
| Normal-vs-Extreme_Obese |
2.092400E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.861800E-01 |
| Normal_Weight-vs-Obese |
6.789800E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.594000E-01 |
| Extreme_Weight-vs-Obese |
1.091770E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.671600E-01 |
| Obese-vs-Extreme_Obese |
4.062800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.740800E-01 |
| Normal-vs-Age(41-60Yrs) |
4.215400E-01 |
| Normal-vs-Age(61-80Yrs) |
3.855500E-03 |
| Normal-vs-Age(81-100Yrs) |
1.737360E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.175800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.570190E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.365800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.699540E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.375600E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.103600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.629050E-01 |
| Normal-VS-Type2 PRCC |
3.184200E-01 |
| Normal-VS-KIRP CIMP |
2.464600E-01 |
| Normal-VS-Unclassified PRCC |
8.394400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.552400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.586200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.723800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.391600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.075200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.603600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.410250E-02 |
| Normal-vs-N1 |
4.368000E-01 |
| Normal-vs-N2 |
8.002000E-01 |
| N0-vs-N1 |
1.137600E-01 |
| N0-vs-N2 |
6.229800E-01 |
| N1-vs-N2 |
6.486600E-01 |
|
|
